New Capital Management LP Johnson & Johnson Transaction History

New Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$161.5 - $179.47 $123,063 - $136,756	-762 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$137.11 - $157.38 $17,687 - $20,302	129 Added 20.38%	762 $119,000
Q4 2019 Jan 10, 2020	SELL	$127.5 - $146.44 $1,912 - $2,196	-15 Reduced 2.31%	633 $92,000
Q3 2019 Oct 09, 2019	BUY	$126.95 - $142.14 $126 - $142	1 Added 0.15%	648 $83,000
Q2 2019 Jul 11, 2019	SELL	$131.15 - $144.24 $1,049 - $1,153	-8 Reduced 1.22%	647 $90,000
Q1 2019 Apr 19, 2019	BUY	$125.72 - $139.79 $2,891 - $3,215	23 Added 3.64%	655 $92,000
Q4 2018 Jan 18, 2019	SELL	$122.84 - $147.84 $31,324 - $37,699	-255 Reduced 28.75%	632 $82,000
Q3 2018 Oct 05, 2018	BUY	$121.58 - $142.88 $3,768 - $4,429	31 Added 3.62%	887 $122,000
Q1 2018 Apr 12, 2018	BUY	$125.1 - $148.14 $125 - $148	1 Added 0.12%	856 $110,000
Q3 2017 Oct 23, 2017	BUY	$129.47 - $135.38 $110,696 - $115,749	855	855 $111,000

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of New Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on New Capital Management LP with notifications on news.